ORBIMED ADVISORS LLC 13D and 13G filings for Compass Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-11 7:21 pm Sale |
2024-04-09 | 13D | Compass Therapeutics, Inc. CMPX |
ORBIMED ADVISORS LLC | 15,219,994 11.000% |
-3,571,428 (-19.01%) |
Filing |
| 2024-03-22 4:59 pm Unchanged |
2024-03-21 | 13D | Compass Therapeutics, Inc. CMPX |
ORBIMED ADVISORS LLC | 18,791,422 13.700% |
0 (Unchanged) |
Filing |
| 2022-11-10 4:25 pm Purchase |
2022-11-08 | 13D | Compass Therapeutics, Inc. CMPX |
ORBIMED ADVISORS LLC | 18,791,422 14.900% |
719,875 (+3.98%) |
Filing |
| 2021-11-09 5:30 pm Purchase |
2021-11-04 | 13D | Compass Therapeutics, Inc. CMPX |
ORBIMED ADVISORS LLC | 18,071,547 18.400% |
5,357,143 (+42.13%) |
Filing |
| 2021-07-14 5:08 pm Purchase |
2021-07-09 | 13D | Compass Therapeutics, Inc. CMPX |
ORBIMED ADVISORS LLC | 12,714,404 20.400% |
12,714,404 (New Position) |
Filing |